Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)
Vietnam · Delayed Price · Currency is VND 139,800
+1,300 (0.94%)
At close: May 18, 2026
HNX:PMC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 82,530 | 82,305 | 80,133 | 83,564 | 83,416 | 64,760 |
Depreciation & Amortization | 13,691 | 11,858 | 11,432 | 11,938 | 12,543 | 13,968 |
Other Amortization | 150.07 | 150.07 | - | - | - | - |
Loss (Gain) From Sale of Assets | -2,918 | -4,647 | -9,496 | -19,973 | -14,121 | -8,762 |
Provision & Write-off of Bad Debts | 9.81 | 9.81 | 31.82 | -452.19 | -407.62 | 250.65 |
Other Operating Activities | -24,479 | -22,968 | -25,378 | -17,783 | -24,712 | -12,664 |
Change in Accounts Receivable | -45,448 | -10,770 | -14,356 | -5,505 | 3,870 | -4,925 |
Change in Inventory | -29,032 | -32,811 | -3,875 | 37,302 | -33,167 | 18,035 |
Change in Accounts Payable | 13,930 | 24,972 | 16,445 | 6,564 | 7,741 | -6,550 |
Change in Other Net Operating Assets | -20,544 | -27,390 | -955.6 | -965.78 | 1,831 | -1,266 |
Operating Cash Flow | -12,111 | 20,709 | 53,981 | 94,690 | 36,993 | 62,847 |
Operating Cash Flow Growth | - | -61.64% | -42.99% | 155.97% | -41.14% | -22.11% |
Capital Expenditures | -85,165 | -79,641 | -14,754 | -8,012 | -5,318 | -3,962 |
Sale of Property, Plant & Equipment | 537.3 | 1,202 | - | 175.45 | 1,253 | 334.97 |
Investment in Securities | 140,500 | 140,500 | 108,000 | 7,100 | -13,969 | -130,631 |
Other Investing Activities | 2,381 | 5,985 | 10,144 | 19,392 | 11,834 | 7,473 |
Investing Cash Flow | 29,253 | 68,046 | 103,390 | 18,656 | -6,200 | -126,785 |
Long-Term Debt Issued | - | 20,181 | - | - | - | - |
Long-Term Debt Repaid | - | -20,000 | - | - | - | - |
Net Debt Issued (Repaid) | 58,330 | 181.01 | - | - | - | - |
Common Dividends Paid | -61,248 | -108,457 | -110,542 | -137,548 | -22,770 | -21,655 |
Dividends Paid | -61,248 | -108,457 | -110,542 | -137,548 | -22,770 | -21,655 |
Financing Cash Flow | -2,918 | -108,276 | -110,542 | -137,548 | -22,770 | -21,655 |
Foreign Exchange Rate Adjustments | 1.28 | 1.28 | 2.37 | 1.08 | 0.99 | -3.61 |
Net Cash Flow | 14,226 | -19,520 | 46,832 | -24,201 | 8,024 | -85,596 |
Free Cash Flow | -97,277 | -58,932 | 39,227 | 86,678 | 31,675 | 58,885 |
Free Cash Flow Growth | - | - | -54.74% | 173.65% | -46.21% | -17.07% |
Free Cash Flow Margin | -17.39% | -10.78% | 7.87% | 17.87% | 6.71% | 14.21% |
Free Cash Flow Per Share | -10422.82 | -6314.62 | 4203.23 | 9287.65 | 3394.02 | 6309.63 |
Cash Income Tax Paid | 19,714 | 19,714 | 21,421 | 20,581 | 20,903 | 13,523 |
Levered Free Cash Flow | -76,720 | -32,634 | 38,747 | 104,285 | 37,573 | 65,033 |
Unlevered Free Cash Flow | -76,258 | -32,445 | 38,747 | 104,285 | 37,573 | 65,033 |
Change in Working Capital | -81,095 | -45,998 | -2,742 | 37,396 | -19,726 | 5,294 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.